97 related articles for article (PubMed ID: 11554763)
1. Hydrophobic residues Phe552, Phe554, Ile562, Leu566, and Ile574 are required for oligomerization of anthrax protective antigen.
Ahuja N; Kumar P; Bhatnagar R
Biochem Biophys Res Commun; 2001 Sep; 287(2):542-9. PubMed ID: 11554763
[TBL] [Abstract][Full Text] [Related]
2. Participation of residue F552 in domain III of the protective antigen in the biological activity of anthrax lethal toxin.
Khanna H; Gupta PK; Singh A; Chandra R; Singh Y
Biol Chem; 2001 Jun; 382(6):941-6. PubMed ID: 11501759
[TBL] [Abstract][Full Text] [Related]
3. Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.
Gupta P; Singh A; Chauhan V; Bhatnagar R
Biochem Biophys Res Commun; 2001 Jan; 280(1):158-63. PubMed ID: 11162493
[TBL] [Abstract][Full Text] [Related]
4. Activity of the Bacillus anthracis 20 kDa protective antigen component.
Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
[TBL] [Abstract][Full Text] [Related]
5. Self-association of the transmembrane domain of an anthrax toxin receptor.
Go MY; Kim S; Partridge AW; Melnyk RA; Rath A; Deber CM; Mogridge J
J Mol Biol; 2006 Jun; 360(1):145-56. PubMed ID: 16756998
[TBL] [Abstract][Full Text] [Related]
6. Characterization of membrane translocation by anthrax protective antigen.
Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
[TBL] [Abstract][Full Text] [Related]
7. Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity.
Batra S; Gupta P; Chauhan V; Singh A; Bhatnagar R
Biochem Biophys Res Commun; 2001 Feb; 281(1):186-92. PubMed ID: 11178978
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of a complex between anthrax toxin and its host cell receptor.
Santelli E; Bankston LA; Leppla SH; Liddington RC
Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
[TBL] [Abstract][Full Text] [Related]
9. EMILINs interact with anthrax protective antigen and inhibit toxin action in vitro.
Doliana R; Veljkovic V; Prljic J; Veljkovic N; De Lorenzo E; Mongiat M; Ligresti G; Marastoni S; Colombatti A
Matrix Biol; 2008 Mar; 27(2):96-106. PubMed ID: 17988845
[TBL] [Abstract][Full Text] [Related]
10. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
Gupta M; Alam S; Bhatnagar R
Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
[TBL] [Abstract][Full Text] [Related]
11. Identification of the cellular receptor for anthrax toxin.
Bradley KA; Mogridge J; Mourez M; Collier RJ; Young JA
Nature; 2001 Nov; 414(6860):225-9. PubMed ID: 11700562
[TBL] [Abstract][Full Text] [Related]
12. Anthrax lethal factor (LF) mediated block of the anthrax protective antigen (PA) ion channel: effect of ionic strength and voltage.
Neumeyer T; Tonello F; Dal Molin F; Schiffler B; Orlik F; Benz R
Biochemistry; 2006 Mar; 45(9):3060-8. PubMed ID: 16503661
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1.
Salles II; Voth DE; Ward SC; Averette KM; Tweten RK; Bradley KA; Ballard JD
Cell Microbiol; 2006 Aug; 8(8):1272-81. PubMed ID: 16882031
[TBL] [Abstract][Full Text] [Related]
14. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax.
Sellman BR; Mourez M; Collier RJ
Science; 2001 Apr; 292(5517):695-7. PubMed ID: 11326092
[TBL] [Abstract][Full Text] [Related]
15. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
[TBL] [Abstract][Full Text] [Related]
16. Anthrax protective antigen: efficiency of translocation is independent of the number of ligands bound to the prepore.
Zhang S; Cunningham K; Collier RJ
Biochemistry; 2004 May; 43(20):6339-43. PubMed ID: 15147218
[TBL] [Abstract][Full Text] [Related]
17. Asp 187 and Phe 190 residues in lethal factor are required for the expression of anthrax lethal toxin activity.
Singh A; Chauhan V; Sodhi A; Bhatnagar R
FEMS Microbiol Lett; 2002 Jul; 212(2):183-6. PubMed ID: 12113932
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of peptide-based anthrax toxin inhibitors.
Gujraty K; Sadacharan S; Frost M; Poon V; Kane RS; Mogridge J
Mol Pharm; 2005; 2(5):367-72. PubMed ID: 16196489
[TBL] [Abstract][Full Text] [Related]
19. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen.
Cunningham K; Lacy DB; Mogridge J; Collier RJ
Proc Natl Acad Sci U S A; 2002 May; 99(10):7049-53. PubMed ID: 11997439
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the anthrax toxin protective antigen.
Petosa C; Collier RJ; Klimpel KR; Leppla SH; Liddington RC
Nature; 1997 Feb; 385(6619):833-8. PubMed ID: 9039918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
